Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière's disease or migraine-associated vertigo?;caso clinico di due pazienti con episodi di vertigine recidivante, ipoacusia fluttuante ed emicrania con buona responsività alla terapia profilattica per l'emicrania. malattia di menière o vertigine emicranica?

Acta Otorhinolaryngologica Italica

Volumn 30, Issue 4, 2010, Pages 217-221

  Teggi, R ^a   Fabiano, B ^a   Recanati, P ^a   Limardo, P ^a   Bussi, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Meni re's disease; Migraine; Migraine associated vertigo; Sensorineural hearing loss; Vertigo

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MENIERE DISEASE; MIDDLE AGED; MIGRAINE; PERCEPTION DEAFNESS; REMISSION; VERTIGO;

ADULT; ASPIRIN; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MENIERE DISEASE; MIDDLE AGED; MIGRAINE DISORDERS; PLATELET AGGREGATION INHIBITORS; REMISSION INDUCTION; VERTIGO;

EID: 77958484307     PISSN: 0392100X     EISSN: 1827675X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Gordon AG. Menière's disease. Lancet 2006;367:984.
2. James AL, Thorp MA. Menière's disease. Clin Evid 2003;116:565-73.
3. Committee on Hearing and Equilibrium. Guidelines for the diagnosis and evaluation of therapy in Menière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
4. Menière P. Pathologie auriculaire: memoires sur une lesion de l'oreille interne donnant lieu à des symptoms de congestion cerebrale apoplectiforme. Gaz Med Paris 1861;16:597-601.
5. Rassekh CH, Harker LA. The prevalence of migraine in Menière's disease. Laryngoscope 1992;102:135-8.
6. Radtke A, Lempert T, Gresty MA, et al. Migraine and Menière's disease. Neurology 2002;59:1700-4.
7. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 1984;107:1123-42.
8. Ibekwe TS, Fasunla JA, Ibekwe PU, et al. Migraine and Menière's disease: two different phenomena with frequently observed concomitant occurrences. J Natl Med Assoc 2008;100:334-8.
9. Yoon-He C, Kane MJ, Baloh RW. Familiar clustering of migraine, episodic vertigo, and Menière's disease. Otol Neurotol 2007;29:93-6.
10. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 2003;16:5-13.
11. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999;246:883-92.
12. Teggi R, Colombo B, Bernasconi L, et al. Migrainous vertigo: results of caloric testing and stabilometric findings. Headache 2009;49:435-44.
13. Neuhauser H, Leopold M, von Brevern M, et al. The interrelations of migraine, vertigo and migrainous vertigo. Neurology 2001;56:436-41.
14. Viirre ES, Baloh RW. Migraine as a cause of sudden hearing loss. Headache 1996;36:24-8.
15. Lee H, Lopez I, Ishiyama A, et al. Can migraine damage the inner ear? Arch Neurol 2000;57:1631-4.
16. Baloh RW. Neurotology of migraine. Headache 1997;37:615-21.
17. Shepard NT. Differentiation of Menière's disease and migraine- associated dizziness: a review. J Am Acad Audiol 2006;17:69-80.
18. Dimitri PS, Wall C, Oas JG, et al. Application of multivariate statistics to vestibular testing: discriminating between Menière's disease and migraine associated dizziness. J Vestibular Res 2001;11:53-65.
19. Love JT Jr. Basilar artery migraine presenting as fluctuating hearing loss and vertigo. Otolaryngology 1978;86:450-8.
20. Battista RA. Audiometric findings of patients with migraineassociated dizziness. Otol Neurotol 2004;25:987-92.
21. Bernard PA, Stenstrom RJ. Fluctuating hearing losses in children can be migraine equivalents. Int J Pediatr Otorhinolaryngol 1988;16:141-8.
22. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992;32:300-4.
23. Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002;23:364-71.
24. Mathew NT. The prophylactic treatment of chronic daily headache. Headache 2006;46:1552-64.
25. Silberstein SD, Lipton RB, Dodick DW, et al. The Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007;47:170-80.
26. Silvestrini M, Bartolini M, Coccia M, et al. Topiramate in the treatment of chronic migraine. Cephalalgia 2003;23:820-4.
27. Boyev PK. Menière's disease or migraine? The clinical significance of fluctuating hearing loss with vertigo. Arch Otolaryngol Head Neck Surg 2005;131:457-9.
28. Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2005:462-8.
29. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-76.
30. Mirone L, Altomonte L, Raco A, et al. Cerebral blood flow abnormalities detected by SPECT in Behçet's-syndrome-related psychiatric disorders. Clin Rheumatol 1998;17:75-6.
31. Oshima M, Kikuchi Y, Furui S. Cerebral perfusion impairment with normal magnetic resonance imaging findings in a patient with neuro-Behcet's disease. Clin Nucl Med 2000;25:156-7.
32. Verrotti A, Cieri F, Pelliccia P, et al. Lack of association between antiphospholipid antibodies and migraine in children. Int J Clin Lab Res 2000;30:109-11.
33. Mitsikostas DD. Is migraine really comorbid with systemic lupus erythematosus? Cephalalgia 2004;24:1013-5.
34. Appenzeller S, Costallat LDL. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage. Cephalalgia 2004;24:1024-30.
35. Isenberg DA, Meyrick-Thomas D, Snaith ML, et al. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis 1982;42:735-41.
36. Weder-Cisneros ND, Téllez-Zenteno JF, Cardiel MH, et al. Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Cephalalgia 2004;24:1031-44.
37. Lessa B, Santana A, Lima I, et al. Prevalence and classification of headache in patients with systemic lupus erythematosus. Clin Rheumatol 2006;25:850-3.
38. Glanz BI, Venkatesan A, Schur PH, et al. Prevalence of migraine in patients with systemic lupus erythematosus. Headache 2001;41:285-9.
39. Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol 2002;28:173-89.
40. ACR Ad Hoc Committee of Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
41. Gökçay F, Oder G, Celebisoy N, et al. Headache in primary Sjogren's syndrome: a prevalence study. Acta Neurol Scand 2008;118:189-92.
42. Avci O, Kutlay E, Argon M, et al. Subclinical cerebral involvement in Behcet's disease: a SPECT study. Eur J Neurol 1998;5:49-53.
43. Schuerger RJ, Balaban CD. Organization of coeruleo-vestibular pathways in rats, rabbits and monkeys. Brain Res 1999;30:189-217.
44. Halberstadt AL, Balaban CD. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience 2006;140:1067-77.
45. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 2003;16:5-13.
46. Buisseret-Delmas C, Compoint C, Delfini C, et al. Organisation of reciprocal connections between trigeminal and vestibular nuclei in the rat. J Comp Neurol 1999;409:153-68.
47. Minor LB. Menière's disease and migraine. Arch Otolaryngol Head Neck Surg 2005;131:460.